Clinical trial
SIRONA 2 Trial Heart Failure NYHA Class III
NCT04012944 · Endotronix, Inc., Industry · Active, not recruiting
Key facts
| NCT number | NCT04012944 |
|---|---|
| Title | SIRONA 2 Trial Heart Failure NYHA Class III |
| Official title | A Prospective, Multi-Center, Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class III Heart Failure Patients (SIRONA 2 Trial) |
| Lead sponsor | Endotronix, Inc., Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Heart Failure NYHA Class III |
| Intervention type | Device |
| Interventions | Cordella™ Pulmonary Artery Sensor System |
| Enrollment | 81 |
| Start date | Jun 26, 2019 |
| Primary completion | Oct 30, 2021 |
| Completion | Jul 1, 2027 |
| First posted | Jul 9, 2019 |
| Last update posted | Aug 7, 2025 |
| Countries | Belgium, Germany, Ireland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: